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Background: Celiac disease is characterized by enhanced intestinal paracellular permeability due to alterations of
function and expression of tight junction (TJ) proteins including ZO-1, Claudin-1 and Occludin. Polyamines are
pivotal in the control of intestinal barrier function and are also involved in the regulation of intercellular junction
proteins. Different probiotic strains may inhibit gliadin-induced toxic effects and the Lactobacillus rhamnosus GG
(L.GG) is effective in the prevention and treatment of gastrointestinal diseases. Aims of the study were to
establish in epithelial Caco-2 cells whether i) gliadin affects paracellular permeability and polyamine profile; ii)
co-administration of viable L.GG, heat-killed L.GG (L.GG-HK) or its conditioned medium (L.GG-CM) preserves the
intestinal epithelial barrier integrity. Additionally, the effects of L.GG on TJ protein expression were tested in
presence or absence of polyamines.
Results: Administration of gliadin (1 mg/ml) to Caco-2 cells for 6 h caused a significant alteration of paracellular
permeability as demonstrated by the rapid decrease in transepithelial resistance with a concomitant zonulin release.
These events were followed by a significant increase in lactulose paracellular transport and a slight lowering in
ZO-1 and Occludin expression without affecting Claudin-1. Besides, the single and total polyamine content
increased significantly. The co-administration of viable L.GG (108 CFU/ml), L.GG-HK and L.GG-CM with gliadin
significantly restored barrier function as demonstrated by transepithelial resistance, lactulose flux and zonulin
release. Viable L.GG and L.GG-HK, but not L.GG-CM, led to a significant reduction in the single and total polyamine
levels. Additionally, only the co-administration of viable L.GG with gliadin significantly increased ZO-1, Claudin-1 and
Occludin gene expression compared to control cells. When Caco-2 cells treated with viable L.GG and gliadin were
deprived in the polyamine content by α-Difluoromethylornithine, the expression of TJ protein mRNAs was not
significantly different from that in controls or cells treated with gliadin alone.
Conclusions: Gliadin modifies the intestinal paracellular permeability and significantly increases the polyamine
content in Caco-2 cells. Concomitant administration of L.GG is able to counteract these effects. Interestingly, the
presence of cellular polyamines is necessary for this probiotic to exert its capability in restoring paracellular
permeability by affecting the expression of different TJ proteins.
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Celiac disease (CD) is a chronic inflammatory disease in
the small intestine of genetically predisposed individuals
triggered by the gluten fraction of wheat, rich in glutam-
ine and proline, or the homologous proteins from barley
and rye. The major part of toxic components is con-
tained in gliadin, the alcohol-soluble fraction of gluten.
In humans, the undigested molecules of gliadin are re-
sistant to degradation by gastric, pancreatic, and intes-
tinal brush-border membrane proteases and thus remain
in the intestinal lumen after gluten ingestion [1].
CD is characterized by enhanced paracellular perme-
ability and an impairment in the integrity of the intes-
tinal barrier [2] that allows the interactions of gluten
peptides with antigen-presenting cells in the lamina pro-
pria. Gliadin is rich in glutamine and the presence of nu-
merous glutamine acceptor proteins in the extracellular
matrix could be responsible for the formation of cross-
links between gliadin and matrix proteins. In turn, this
gliadin immobilization to extracellular matrix proteins
could provide a long-term availability of toxic gliadin
fractions in the mucosa [3]. However, there is still much
debate about the possible interactions of gliadin (and/or
its peptide derivatives) with intestinal epithelia and the
mechanism(s) through which it crosses the epithelial
barrier to reach the submucosa [4].
Integrity of the intestinal barrier depends on a complex
of proteins composing different intercellular junctions, in-
cluding tight junctions (TJs) and adherens junctions [5].
Major transmembrane and cytosolic TJ proteins in the
mammalian epithelium include Zonula Occludens ZO-1
and ZO-2, Occludin and Claudins. These proteins are
thought to constitute the backbone of TJ strands and to
modulate some functions of TJs, respectively [6]. ZO-1
and ZO-2 are the cytoplasmic faces of TJs and directly
bind to the COOH terminus of intracellular domain of
Occludin. The interaction between Occludin and ZO-1 or
ZO-2 protein is crucial for maintaining normal structure
of the TJs and epithelial barrier function [6]. Occludin is a
65-kDa integral plasma-membrane protein. Its expression
is markedly decreased in intestinal permeability (IP) disor-
ders, including Crohn’s disease, ulcerative colitis and CD,
suggesting that the lowering in Occludin expression may
play a part in the increase in IP [7]. The Claudin family of
TJ proteins regulates the epithelial paracellular permeabil-
ity. Claudins are 20- to 27-kDa proteins containing 2
extracellular loops with variably charge aminoacid resi-
dues among family members and short intracellular tails
[8]. In intestinal epithelial cells, Claudin-1 expression is
associated with enhancement of epithelial barrier function
[9] and it is found to be decreased in both intestinal and
extraintestinal diseases [10].
Among the several substances involved in the IP con-
trol, polyamines play a crucial role. These polycationiccompounds are ubiquitous short-chain aliphatic amines
present in all the eukaryotic cells studied and regulate
cell proliferation and differentiation [11]. Polyamines are
also involved in the expression and functions of intercellu-
lar junction proteins, as well as in maintenance of intes-
tinal epithelial integrity [12]. With their positive charges,
polyamines can form bridges between distant negative
charges, resulting in unique effects on permeability. The
action of polyamines in modulating IP to different-sized
markers generally seems to depend on their concentration
[13]. Spermidine appears to enhance mucosal permeability
to macromolecules at lower concentration (1 mM), as
compared to putrescine (10 mM).
The protective effect of polyamines on the in vitro tox-
icity of gliadin peptides has been related to their effect
on the functions of intestinal brush border or intracellu-
lar membranes involved in the handling of gliadin and
initial studies suggested that amines could act as transglu-
taminase amino donor substrates in the intestinal metab-
olism of gliadin peptides [14]. However, little is still known
about the direct action of gliadin on the levels of poly-
amines in in vitro cell conditions.
At present, a strict, lifelong gluten-free diet (GFD) is
the only CD treatment. Therefore, alternative strategies
for treating CD are being hypothesized including agents
that are able to counteract the gluten induced damage
on epithelial mucosa.
Probiotic bacteria have been shown to preserve the intes-
tinal barrier promoting its integrity both in vitro and
in vivo [15,16]. Besides, different probiotic strains may
show promising abilities in inhibiting gliadin-induced toxic
effects [17] and a particular lactobacillus strain, the Lacto-
bacillus rhamnosus GG (ATCC 53103) (L.GG), has shown
properties in the prevention and treatment of different
gastrointestinal diseases [18]. L.GG is one of the clinically
best-studied probiotic organisms and displays very good
in vitro adherence to epithelial cells and mucus. In previ-
ous studies by our group this strain, when tested as both
viable and heat inactivated bacteria as well as homogenate
and cytoplasm extracts, has also been demonstrated
in vitro to significantly affect cell proliferation and poly-
amine metabolism [19,20].
On these bases, the present in vitro study aimed at an-
swering to the following questions: a) does gliadin affect
the paracellular permeability and polyamine profile? b)
does concomitant administration of viable L.GG, heat-
killed L.GG or its conditioned medium preserve the in-
testinal epithelial barrier, after disruption with gliadin? c)
what are their effects on the TJ protein expression? The
role of cellular polyamines as a requisite for L.GG action
on the expression of TJ proteins was also investigated.
As in vitro model of CD the Caco-2 cell line was
used. This line is formed by intestinal epithelial cells ob-
tained from human colon adenocarcinoma, that, before
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provides an important and widely used tool for studying
and obtaining greater insight into the molecular and cellu-
lar mechanisms of CD alterations in epithelial cells [21].
Methods
Cell culture conditions
Human colon adenocarcinoma-derived Caco-2 cells were
obtained from the Interlab Cell Line Collection (IST,
Genoa, Italy). Cells were routinely cultured in RPMI-1640
medium supplemented with 10% fetal bovine serum
(FBS), 2 mM glutamine, 100 U/ml penicillin, 100 μg/ml
streptomycin, in a monolayer culture, and incubated at
37°C in a humidified atmosphere containing 5% CO2 in
air. At confluence, the grown cells were harvested by
means of trypsinization and serially subcultured with a 1:4
split ratio. All cell culture components were purchased
from Sigma-Aldrich (Milan, Italy).
Bacterial strain
As probiotic, the Lactobacillus rhamnosus ATCC 53103
(commercially named Lactobacillus GG, L.GG, obtained
from the American Type Culture Collection ATCC,
Manassas, VA USA) was tested in our set of experiments.
L.GG was cultured at 37°C for 24 h under anaerobic
conditions in Man-Rogosa-Sharpe (MRS) broth; the
incubate was centrifuged (300 × g for 10 min) at room
temperature and the precipitate was collected and washed
twice with phosphate buffered saline (PBS) at pH 7.4. The
bacteria were then re-suspended in RPMI-1640 medium
in order to give a bacterial concentration of 108 CFU/ml
(as determined by colony counts). Heat-treatment of L.
GG was performed by heating at 95°C for 1 h. Bacterial
conditioned medium (CM) was collected by centrifugating
the incubate at 300 × g for 10 min. The supernatant (con-
ditioned medium) was filtered through a 0.22 μm low-
protein-binding filter (Millex; Millipore, Bedford, MA) to
sterilize and remove all bacterial cells. Aliquots of L.GG-
CM were stored in sterile microcentrifuge tubes at −20°C
until use. Caco-2 cells were treated with LGG-CM as a
10% volume of the total incubation cell medium.
Gliadin and L.GG treatments
Caco-2 cells (25th-30th passage) were seeded at a dens-
ity of 2 × 105 cells/5 ml of supplemented RPMI-1640 in
60 mm tissue culture dishes (Corning Costar Co., Milan,
Italy). After 24 h, to allow for attachment, the medium
was removed and RPMI-1640 supplemented with 10% FBS
and 2 mM glutamine, containing viable L.GG (108 CFU/
ml), L.GG-heat killed (L.GG-HK), L.GG-CM were added
to cells for 6 h. A concomitant set of experiments was con-
ducted by administering for the same time 1 mg/ml wheat
gliadin (Sigma-Aldrich) alone or in combination with
viable L.GG, L.GG-HK and L.GG-CM. Triplicate cultureswere set up for each treatment and for the control, and
each experiment was repeated 3 times.
In the experiments investigating the transepithelial re-
sistance (TER), zonulin release and lactulose flux after
the above cited treatments, Caco-2 cells were plated onto
Millicell Culture inserts (Millipore Corporate, Billerica,
MA, USA); 2 ml of supplemented RPMI was added to the
mucosal (apical) side and 3 ml of the same medium was
added to the serosal (basolateral) side. Cells were incu-
bated at 37°C in an atmosphere of 95% air and 5% CO2
and grown until confluence (average 10–15 days post-
seeding). Then, the monolayer was washed with PBS twice
and incubated with RPMI supplemented as above but
without antibiotics. Replicates of Caco-2 monolayers
were incubated at increasing time intervals (0–30 min -
60 min- 90 min - 3 h - 6 h) after undergoing the above
described gliadin and L.GG treatments. The prepara-
tions were added to the mucosal (apical) side of the
Caco-2 monolayers.Transepithelial resistance measurements
The resistance of the cell monolayer was measured using
a Millicell-ERS volt-ohm meter (Millipore Corporate).
Caco-2 cells were regarded as confluent when TER
exceeded 600 ohms/cm2 [17]. Confluent monolayers were
washed twice with PBS and incubated overnight in RPMI
medium supplemented with 10% FBS and 2 mM glutam-
ine but without antibiotics prior to gliadin and L.GG
treatments. After cell exposure to bacteria and/or gliadin,
TER was measured immediately after changing the media
as well as after 30 min, 60 min, 90 min, 3 h, and 6 h.Measurement of lactulose flux from the apical to
basolateral side of Caco-2 monolayers
Lactulose, a probe used to check paracellular permeabil-
ity, was added at 40 mM/ml final concentration to the
apical side of all monolayers at time 0. Samples were
collected from the basolateral side at increasing time in-
tervals (ranging from 30 min to 6 h) after gliadin and L.
GG treatments. Lactulose concentration was measured
by high performance anion exchange chromatography
(HPAEC) [22]. After deproteination with acetonitrile
1:1 v/v, samples were centrifuged at 4000 rpm for 10 min,
the supernatant collected, filtered through a 0.22 mm
membrane (Millipore, Bedford, Mass., USA), and diluted
with water 1 to 10 (basolateral samples) or 1 to 100 (apical
samples). HPAEC coupled with pulsed amperometric de-
tection (HPAEC-PAD) was performed on a Dionex Model
ICS-5000 with a gold working electrode and a 25 μl peek
sample loop (Dionex Corp., Sunnyvale, CA, USA). Carbo-
hydrate separation was carried out by a Carbopac PA-10
pellicular anion-exchange resin connected to a Carbopac
PA-10 guard column at 30°C.
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Zonulin content from cell culture media was quantified
at increasing time intervals (ranging from 30 min to 6 h)
after gliadin and L.GG treatments, using the zonulin
enzyme-linked immunosorbent assay (Elisa) kit (Immu-
nodiagnostik, Bensheim, Germany) [23].Polyamine analysis
For the evaluation of polyamine levels after gliadin and
L.GG treatments for 6 h, each cell culture pellet was ho-
mogenized in 700 μl of 0.9% sodium chloride mixed with
10 μl (200 nmol/ml) of the internal standard 1,10-diami-
nodecane (1,10-DAD). An aliquot of the homogenate
was used to measure the total protein content. Then, to
precipitate proteins, 50 μl of perchloride acid (PCA)
3 M were added to the homogenate. After 30 min of
incubation in ice, the homogenate was centrifuged for
15 min at 7000 × g. The supernatant was filtered (Millex-
HV13 pore size 0.45 μm, Millipore, Bedford, MA, USA)
and lyophilized. The residue was dissolved in 300 μl of
HCL (0.1 N). Dansylation and the extraction of dansyl-
polyamine derivatives were performed as previously de-
scribed [24]. After extraction, aliquots of 200 μl were
injected into a high-performance liquid chromatography
system (UltiMate 3000, Dionex Corp., Sunnyvale, CA,
USA) equipped with a reverse-phase column (Sunfire
C18, 4.6 × 100 mm, 3.5 μm particle size, Waters, Milford,
MA, USA). Polyamines were eluted with a linear gradient
ranging from acetonitrile-water (50:50, v:v) to acetonitrile
(100%) for 30 min. The flow was 0.5-1.0 ml/min from 0 to
12 min and then set at a constant rate (1.0 ml/min) until
the 30th min. The fluorescent intensity was monitored by
a fluorescence detector (UltiMate 3000 RS, Dionex Corp.,
Sunnyvale, CA, USA) with excitation at 320 nm and emis-
sion at 512 nm. Polyamine levels were expressed as con-
centration values in nmol/mg of protein.Table 1 Sequences of amplification primers
Gene Primer
ZO-1 Sense 5′- ATCCCTCAAGGAGCCATTC-3′
Antisense 5′- CACTTGTTTTGCCAGGTTTTA-3′





Antisense 5′-CGTCATACTCCTGCTTGCT GATCCACATCTGC-3ZO-1, claudin-1 and occludin expression
The effects of gliadin and L.GG treatments for 6 h and
24 h on ZO-1, Claudin-1 and Occludin mRNA and pro-
tein levels in Caco-2 cells were evaluated using the
quantitative PCR (qPCR) method with SYBR1 green dye
and Western Blot analysis, respectively. Besides, to in-
vestigate whether the potential changes in TJ expression
following to the combined administration of viable L.GG
with gliadin could be related to the polyamine content,
the cells were cultured with α-Difluoromethylornithine
(DFMO) 5 mM for 4 days before undergoing the same
treatment for 6 h. DFMO is a specific inhibitor of poly-
amine synthesis and, as reported in literature, at a con-
centration of 5 mM, it is able to completely deplete
putrescine within 48 h and to totally deplete spermidine
and reduce by 60% spermine within 4 days [25].Cells were washed twice in PBS and then trypsinized and
centrifuged at 280 × g. The cell pellets were resuspended in
0.3 ml of pure distilled water and used for RNA extraction.
Total cell RNA was extracted using Tri-Reagent (Mol. Res.
Center Inc., Cincinnati, Ohio, USA), following the manu-
facture’s instruction. About 2 μg total cell RNA, extracted
from both the control and treated cells, was used for
cDNA synthesis. Reverse transcription (RT) was carried
out in 20 μl of the final volume at 41°C for 60 min, using
30 pmol antisense primer (Table 1) for analyses of the
ZO-1, Claudin-1, Occludin and the β-actin gene [26].
The β-actin gene was utilized as an internal control and
was chosen as a reference gene because it is a house-
keeping gene. Real-time PCRs were performed in 25 μl
of final volume containing 2 μl of cDNA, master mix
with SYBR Green (iQ SYBR Green Supermix Bio-Rad,
Milan, Italy) and sense and antisense primers for the
ZO-1, Claudin-1, Occludin and the β-actin gene (Table 1).
Real-time PCRs were carried out in a CFX96 Real-Time
PCR Detection System (Bio-Rad Laboratories, Inc.) using
the following protocol: 45 cycles at 95°C for 3 min, 95°C
for 10 s, 55°C for 30 s followed by a melting curve step at
65 – 95°C with a heating rate of 0.5°C per cycle for 80 cy-
cles. The PCR products were quantified by external cali-
bration curves, one for each tested gene, obtained with
serial dilutions of known copy number of molecules (102-
107 molecules). All expression data were normalized by
dividing the target amount by the amount of β-actin used
as internal control for each sample. The specificity of the
PCR product was confirmed by gel electrophoresis.
As Western Blot concerns, Caco-2 cells were collected
and lysed on ice in RIPA buffer (Pierce Ripa buffer, Thermo
Scientific, Rockford, IL, USA). After homogenization and
centrifugation at 14000 rpm for 15 min at 4°C, protein
concentration was measured by a standard Bradford assay
(Bio-Rad Laboratories, Milan, Italy). Aliquots of 50 μg of
total proteins were separated in 4-12% pre-cast polyacryl-
amide gels (Invitrogen, Life Technologies, OR, USA) and
transferred onto a PVDF membrane (Bio-Rad Laboratories,
Milan, Italy) with Transblot Turbo (Bio-Rad Laboratories).
ZO-1, Claudin-1, Occludin and β-actin protein expressions
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(D-4), Occludin (N-19) and β-actin antibody, respectively
(Santa Cruz Biotechnology, Santa Cruz, CA, USA). After
overnight incubation, the membranes were further incu-
bated with a horseradish peroxidase-conjugated goat sec-
ondary antibody (Bio-Rad Laboratories). The proteins were
detected by chemiluminescence (ECL, Thermo Scientific,
Rockford, IL, USA) and the densitometric analysis of each
protein-related signal was obtained using the Molecular
Imager Chemidoc™ (Bio-Rad Laboratories) and normalized
against β-actin expression.Statistical analysis
Due to the non-normal distribution of the data, non-
parametric tests were performed. Data were analyzed by
Kruskal-Wallis analysis of variance and Dunn’s Multiple
Comparison Test. In order to evaluate the release of
zonulin during the time of observation, the area under
the curve (AUC) was calculated. All data are expressed
as mean and SEM. Differences were considered signifi-
cant at P < 0.05. A specific software package (SigmaStat
for Windows version 3.00 SPSS Inc. San Jose, CA, USA)
was used.Results
Effects of gliadin and L.GG treatments on Caco-2
monolayer barrier function (TER and lactulose flux)
TER measurements were determined after the addition
of viable L.GG, L.GG-HK and L.GG-CM to polarized
monolayers of Caco-2 cells seeded on Transwell filter in-
serts. TER was measured before the addition of bacteria,
at time zero (immediately after the bacteria administra-
tion) and then at various time intervals ranging from
30 min to 6 h. A slight and not significant increase in
TER was observed after 90 min from the addition of
viable L.GG, as well as L.GG-HK and L.GG-CM to
Caco-2 cells compared to control cells (data not shown).Figure 1 Effects of supplementation of viable L.GG (108 CFU/ml), L.GG
data represent the results of three different experiments (mean ± SEM). For
of variance and Dunn’s Multiple Comparison Test. (*) P < 0.05 compared toAddition of gliadin to the mucosal side of Caco-2 mono-
layers led to an immediate lowering in TER (Figure 1).
The TER of gliadin-treated Caco-2 cells immediately after
the gliadin administration (time zero) decreased to 30% of
TER measured before treatment and started to recover
after 90 min of incubation. The co-administration of
viable L.GG, L.GG-HK and L.GG-CM with gliadin had a
significant (P < 0.05) reversible effect on the recovery of
TER starting 60 min post-incubation compared to gliadin-
treated cells. After 6 h, the reversion of TER of viable L.
GG, L.GG-HK and L.GG-CM to gliadin-treated cells
reached 90%, 76% and 80% of their initial values before
the addition of gliadin.
To confirm that TER reduction involved the opening
of intercellular TJs, the mucosal to serosal transport of
the paracellular marker lactulose was also monitored.
No effect on lactulose flux was observed after 90 min
from the addition of viable L.GG, as well as L.GG-HK
and L.GG-CM to Caco-2 cells compared to control cells
(data not shown). By opposite, in monolayers treated
with gliadin, a significant increase (P < 0.05) in serosal
lactulose (0.077 ± 0.04 μg/ml) was observed 90 min after
gliadin exposure compared to untreated monolayers
(0.025 ± 0.02 μg/ml). The co-administration of viable L.
GG, L.GG-HK and L.GG-CM antagonized the increased
paracellular lactulose transport due to gliadin treatment
(viable L.GG: 0.03 ± 0.02 μg/ml; L.GG-HK: 0.039 ± 0.01 μg/
ml; L.GG-CM: 0.04 ± 0.01 μg/ml).
Effects of gliadin and L.GG treatments on zonulin release
Viable L.GG, L.GG-HK and L.GG-CM were adminis-
tered to Caco-2 cells at different times (ranging from 0
to 6 h). No effect on zonulin release was observed (data
not shown). The incubation of Caco-2 cells with gliadin
led to a significant (P < 0.05) luminal secretion of zonu-
lin starting from 30 min post-incubation (Figure 2).
Zonulin release reached baseline values after 6 h of ex-
posure. The co-administration of viable L.GG, L.GG-HK-HK and L.GG-CM on gliadin-induced (1 mg/ml) TER decrease. All
each time of treatment, data were analyzed by Kruskal-Wallis analysis
gliadin treated cells.
Figure 2 Zonulin release in Caco-2 monolayers exposed to gliadin (1 mg/ml) alone or in combination with viable L.GG (108 CFU/ml),
heat killed L.GG (L.GG-HK) and L.GG conditioned medium (L.GG-CM). All data represent the results of three different experiments (mean ±
SEM). For each time of treatment, data were analyzed by Kruskal-Wallis analysis of variance and Dunn’s Multiple Comparison Test. (*) P < 0.05
gliadin vs. gliadin + Viable L.GG.
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lease induced by gliadin. The differences in the zonulin
levels were significant between cells treated with gliadin
and cell treated with gliadin and viable L.GG at 30 min,
60 min and 90 min (P < 0.05) (Figure 2).
In order to calculate the differences in the zonulin re-
lease over the time of exposure to gliadin alone or in
combination with viable L.GG, L.GG-HK and L.GG-CM
at different times (ranging from 0 min to 6 h), the AUCs
of zonulin were calculated. The AUC value was higher
in the gliadin-treated Caco-2 cells (14.06 ± 0.54) com-
pared to those in cells treated with gliadin and viable L.
GG (9.86 ± 0.28), gliadin and L.GG-HK (11.20 ± 0.33)
and gliadin and L.GG-CM (11.93 ± 0.45). The difference
was significant (P = 0.02) between Caco-2 cells treated
with gliadin alone and cells treated with gliadin and
viable L.GG.
Effects of gliadin and L.GG treatments on the polyamine
profile
The effects of viable L.GG, L.GG-HK and L.GG-CM on
the polyamine profile of Caco-2 cell line were studied
(Table 2). The administration of viable L.GG and L.GG-
HK, but not L.GG-CM, led to a decrease of the single
and total polyamine contents. The decrease was signifi-
cant (P < 0.05) for spermidine, spermine and the total
polyamine content compared to untreated control cells.Table 2 Polyamine profile in Caco-2 cells after 6 h of exposur
alone or in combination with gliadin (1 mg/ml)
Control Viable L.GG L.GG-HK L.GG-CM Glia
Putrescine 0.15 ± 0.1a 0.12 ± 0.1a 0.1 ± 0.2a 0.12 ± 0.1a 0.2 ± 0
Spermidine 6.9 ± 0.08a 3.3 ± 0.1c 3.8 ± 0.2c 6.8 ± 0.09a 9.3 ±
Spermine 7.8 ± 0.05a 4.3 ± 0.04c 5.3 ± 0.5c 7.5 ± 0.05a 11.1 ±
Total polyamines 14.3 ± 0.3a 7.9 ± 0.5c 9.1 ± 0.6c 14.4 ± 0.5a 20.9 ±
All data represent the results of three different experiments (mean ± SEM). For each
(P < 0.05, Kruskal-Wallis analysis of variance and Dunn’s Multiple Comparison Test).The administration of gliadin to Caco-2 cells led to a
significant increase (P < 0.05) in the spermidine (+35%),
spermine (+42%) and total polyamine content (+46%) in
comparison with untreated control cells.
The supplementation of viable L.GG and L.GG-HK,
but not L.GG-CM, on gliadin treated cells counteracted
significantly (P < 0.05) the effects of gliadin on the poly-
amine profile. In particular, the contents in spermidine
and spermine decreased by 35.5% and 61.3%, respect-
ively for viable L.GG. Overall, the percentage of reduc-
tion in the total polyamine content was by 50.7%. As
concerns cells treated with gliadin and L.GG-HK, the re-
duction in spermidine and spermine content was equal
to 23.6% and 19.8%, respectively. The total polyamine
content was reduced by 23.9%.
Effects of gliadin and L.GG treatments on ZO-1, Claudin-1
and Occludin expression
To establish whether the changes in paracellular perme-
ability on Caco-2 monolayers following gliadin and L.GG
treatments were associated with modifications in ZO-1,
Claudin-1 and Occludin expression, mRNA and protein
levels of the three proteins were quantified by qPCR and
Western Blot analysis, respectively.
When Caco-2 cells were exposed to viable L.GG, L.
GG-HK and L.GG-CM for 6 h, a significant (P < 0.05)
increase in the ZO-1, Claudin-1 and Occludin mRNAe to viable L.GG (108 CFU/ml), L.GG-HK and L.GG-CM,
din Gliadin + Viable L.GG Gliadin + L.GG-HK Gliadin + L.GG-CM
.005a 0.2 ± 0.008a 0.16 ± 0.005a 0.2 ± 0.01a
0.05b 6.0 ± 0.06a 7.1 ± 0.05a 8.2 ± 0.2ab
0.3b 4.3 ± 0.1c 8.9 ± 0.03a 11.3 ± 0.09 ab
0.8b 10.3 ± 0.4c 15.9 ± 0.3a 20.01 ± 0.5b
treatment mean values not sharing a common superscript differ significantly
Polyamines are in nmol/mg protein.
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viable bacteria treatment (Figure 3, panels A, B, and C).
The administration of gliadin did exert a slight and not
significant down-regulatory effect on ZO-1 (−20.6%) and
Occludin (−17.5%) expression, without affecting Claudin-
1 one. By opposite, only the administration of viable L.GG
in combination with gliadin caused a significant (P < 0.05)
increase in the mRNA levels of all the tested proteins. In
particular, ZO-1 and Claudin-1 increased more than
tenfold and Occludin more than fourfold compared to
gliadin-treated cells (Figure 3, panels D, E, and F).
L.GG-HK and L.GG-CM in combination with gliadin
did not exert any significant effect on mRNA levels of
the three proteins.
This finding was a little contradictory. It would be ex-
pected to see differences also in the TJ mRNA levels of
the gliadin treated cells compared to controls. Therefore,
ZO-1, Claudin-1 and Occludin expressions were evalu-
ated in function of the time, following 24 h of exposure.
ZO-1 and Claudin-1 mRNA levels were significantly
(P < 0.05) affected by exposure to gliadin compared to
untreated control cells. In particular ZO-1 expressionFigure 3 ZO-1, Claudin-1 and Occludin mRNA levels in Caco-2 monola
treatments. Panels A, B, and C report ZO-1, Claudin-1 and Occludin mRNA
(108 CFU/ml), heat killed L.GG (L.GG-HK) and L.GG conditioned medium (L.G
Dunn’s Multiple Comparison Test. (*) P < 0.05 compared to control cells. Pa
Caco-2 monolayers after 6 h of exposure to gliadin (1 mg/ml) alone or in c
analyzed by Kruskal-Wallis analysis of variance and Dunn’s Multiple Compar
represent the results of three different experiments (mean ± SEM).decreased by 25% (0.80 ± 0.04 vs. 0.60 ± 0.01) while
Claudin-1 decreased by 80% (0.05 ± 0.02 vs. 0.01 ± 0.01).
Occludin expression remained unchanged (0.04 ± 0.02
vs. 0.035 ± 0.02). These results suggest that gliadin may
be involved in the regulation of the TJ expression in a
time dependent fashion. The administration of viable L.
GG in combination with gliadin continued to signifi-
cantly (P < 0.05) increase the mRNA levels of Claudin-1
(2.27 ± 0.06 vs. 0.037 ± 0.01) and Occludin (1.3 ± 0.02 vs.
0.12 ± 0.02) while exerting a slight and not significant
decrease on ZO-1 expression (0.79 ± 0.02 vs. 1.04 ± 0.04)
compared to gliadin treated cells.
Given that only viable L.GG was effective in modulating
TJ expression, alone or in combination with gliadin, we in-
vestigated whether the presence of cellular polyamines
could affect the action of viable L.GG on TJ protein ex-
pression. Therefore, a subsequent set of experiments was
conducted also in absence of polyamines by treating
Caco-2 cells with DFMO for 6 h. The addition of gliadin
to cells did not significantly influence the expression of all
the proteins. Interestingly, also the supplementation of vi-
able L.GG to gliadin did not produce consequences on theyers after 6 h of exposure to different probiotic and gliadin
levels in Caco-2 monolayers after 6 h of exposure to viable L.GG
G-CM). Data were analyzed by Kruskal-Wallis analysis of variance and
nels D, E and F report ZO-1, Claudin-1 and Occludin mRNA levels in
ombination with viable L.GG, L.GG-HK and L.GG-CM. Data were
ison Test. (*) P < 0.05 compared to gliadin treated cells. All data
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evidence suggests the need of polyamines by this probiotic
to exert its actions on TJ protein expression (Figure 4,
panels A, B, and C).
Overall, Western Blot analysis confirmed the results
obtained by qPCR at 6 h and 24 h. In particular, Figure 5
reports the results obtained at 6 h. The protein levels of
ZO-1 and Occludin in Caco-2 cells decreased not sig-
nificantly after treatment with gliadin alone compared to
control cells. Claudin-1 was not affected in its levels. Be-
sides, the co-administration of gliadin with viable L.GG,
but not with L.GG-HK and L.GG-CM, led to a signifi-
cant increase (P < 0.05) in the levels of ZO-1 (twofold),
Claudin-1 (twofold) and Occludin (fourfold) compared
to gliadin-treated cells.
Discussion
In physiological conditions, intestinal epithelium is imper-
meable to macromolecules, but in CD patients the gliadin
fraction of wheat gluten represents the environmental
factor responsible for the alterations in the junctional
structures between epithelial cells leading to compromised
permeability [4].
In our in vitro conditions, administration of gliadin to
Caco-2 cells caused an increase in paracellular perme-
ability as demonstrated by the dramatic decrease in TER
immediately after the exposure, with a concomitant re-
lease of zonulin. These events were followed at 90 min
by a significant rising in the lactulose paracellular trans-
port. Overall, the process was rapid. After 6 h from expos-
ure, the release of zonulin was similar to baseline values. It
is now accepted that one of the immediate consequences
of gluten exposure is the increased paracellular permeabil-
ity, occurring within 36 h [27] and our observations alongFigure 4 ZO-1, Claudin-1 and Occludin mRNA levels in Caco-2 monolaye
with viable L.GG (108 CFU/ml), in presence or absence of polyamines
All data represent the results of three different experiments (mean ± SEM).
levels. Data were analyzed by Kruskal-Wallis analysis of variance and Dunn’s
treated cells.with data in literature from in vivo studies, support that
this is an early event rather than a consequence of chronic
intestinal inflammation [22].
CD patients show structural alterations at TJs that are
made up of transmembrane proteins such as Occludins,
and Claudins with intra-cellular connections to the
Zonulins, which are members of the ZO family. These,
in turn, are anchored to the cell’s actinomyosin cytoskel-
eton and the result is a structure that not only provides
the epithelium with a barrier function but also, by rapid
assembly and disassembly, changes its permeability upon
different stimuli [28]. In our study, ZO-1, Claudin-1 and
Occludin expression was assessed to test their involve-
ment in modifications of paracellular permeability of
Caco-2 cells. When these cells were exposed to gliadin, a
time dependent effect on TJs expression was observed.
After 6 h of gliadin exposure, a slight and not significant
decrease in ZO-1 and Occludin expression occurred with-
out affecting Claudin-1. By prolonging the time of expos-
ure up to 24 h, ZO-1 and Claudin-1 expressions decreased
significantly while Occludin expression remained un-
changed. This evidence let us hypothesize that the con-
tinuous exposure to a toxic agent such as gliadin could
bring cells to a rearrangement in TJ architecture, beyond
the immediate disruption of the epithelial barrier. Few
data are available on this item. Previously, Sander et al.
[29] reported a fast disruption of intestinal barrier func-
tion in Caco-2 cells (after 4 h of exposure to gliadin
peptic-tryptic digest) that markedly involved Occludin,
ZO-1 and E-cadherin. In our study, the events were not so
rapid even if, in agreement with these authors, we also
found that permeability, as measured by TER, increased
immediately after gliadin addition reaching its maximum
after 60 minutes. The differences in TJ expression betweenrs after 6 h of exposure to gliadin (1 mg/ml) alone or in combination
following administration of α-Difluoromethylornithine (DFMO).
A. ZO-1 mRNA levels; B. Claudin-1 mRNA levels; C. Occludin mRNA
Multiple Comparison Test. (*) P < 0.05 compared to gliadin
Figure 5 Western Blot analysis of ZO-1, Claudin-1 and Occludin (using their specific antibodies as specified in Methods) in Caco-2
monolayers after 6 h of exposure to gliadin (1 mg/ml) alone or in combination with viable L.GG (108 CFU/ml), heat killed L.GG
(L.GG-HK) and L.GG conditioned medium (L.GG-CM). Immunoreactive bands were quantified using Quantity One programme. The diagrams
show quantification of the intensity of bands, calibrated to the intensity of the β-actin bands. All data represent the results of three different
experiments (mean ± SEM). Data were analyzed by Kruskal-Wallis analysis of variance and Dunn’s Multiple Comparison Test. (*) P < 0.05 compared
to gliadin treated cells.
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tered. In fact, we used wheat gliadin instead of the peptic-
tryptic (PT) digests that are known to have different
modes of action in regard to their toxicity. PT treatment
induces the production of alkenals that in turn can
modify the activity of membrane-associated proteins
and enzymes [30].The modifications in paracellular permeability went to-
gether with a rising in the single and total polyamine con-
tent that was evident and significant after 6 h of exposure.
A clear role for polyamines at cellular and molecular levels
in the gliadin-triggered damage of intestinal epithelia is
still under debate. Regulation of brush border functions
by spermidine and spermine has been suggested to be
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polyamines into membrane proteins [31]. Besides, it has
been hypothesized that epithelial binding of gliadin pep-
tides may occur in the form of IgA immune complexes
which then translocate across the epithelium [32]. This
binding could represent powerful extraneous growth fac-
tors for the gut and, as a result, induce extensive prolifera-
tion and changes in the metabolism of epithelial cells via
activation of second messenger pathways. These metabolic
changes may release huge amounts of polyamines, mostly
spermidine [33]. On the other hand, the increase in poly-
amine content probably results from increased cell prolif-
eration during the repair phase of mucosal injury. In this
context, polyamine levels could be regarded as markers of
a hyperproliferative state in response to toxic effects of
gliadin. This behavior by polyamines has already been re-
ported during inflammation of intestine leading to de-
rangement of the mucosa [34].
The second aim of the study was to investigate the pos-
sible effects on paracellular permeability and polyamine
content following co-administration of viable L.GG, LGG-
HK or its conditioned medium with gliadin. In previous
experiments by our group, L.GG was proven to be effect-
ive in modulating cell proliferation and polyamine metab-
olism and biosynthesis also when its components (namely
cytoplasm extracts and cell wall extracts) were tested,
supporting the hypothesis that intact cells is not a pre-
requisite for the L.GG protective effects [19,20].
Although members of the Lactobacillus genera are a
subdominant part of the normal colonic microbiota, they
represent a much greater component higher up in the
gut [35]. Animal models and cell culture systems have
provided indications that lactobacilli are able to counter-
act alterations in paracellular permeability evoked by cy-
tokines, chemicals, peptides, infections or stress [36]. A
paper by Seth et al. [37] reported that the administration
of live and heat inactivated L.GG, bacterial supernatants
and peculiar L.GG purified soluble proteins to Caco-2
cells treated by hydrogen peroxide that destroys TER
and increases permeability, caused the secretion of pro-
teins of this strain effective against the insult.
In our study, the administration of viable and heat
killed L.GG as well as its conditioned medium, caused
only a slight and not significant increase in TER after
90 min from exposure without any effects on lactulose
flux and zonulin release. By opposite, in Caco-2 cells
treated with gliadin, the addition of viable L.GG, but also
L.GG-HK and L.GG-CM, significantly restored cell bar-
rier function. Also the single and total polyamine levels
diminished significantly when Caco-2 cells were exposed
to gliadin in combination with viable and heat killed L.
GG. Recently, our group reported that the administra-
tion of viable, heat killed L.GG and L.GG homogenate
to DLD-1 and HGC-27 cell lines significantly reducedneoplastic proliferation as well as polyamine content and
biosynthesis [19,20,38].
As regards the protective effects of some probiotics
against gliadin, our findings are in line with data in lit-
erature [39] and different mechanisms could be evoked
to explain the effects exerted by L.GG, not only as viable
bacteria, but also when they were heat inactivated or
their conditioned medium was used. Firstly, L.GG might
inhibit gliadin-induced damage in Caco-2 cells by hydro-
lyzing gliadin similarly to other live probiotic bacteria as
in the VSL3# probiotic preparation [40]. These strains
showed the ability to colonize the human stomach and
duodenum, where the hydrolysis of gliadin epitopes may
be relevant for decreasing the abnormal secretion of zonu-
lin and the initial step of immune response to gliadin
[41,42]. Secondly, the peculiar set of peptidases shown by
L.GG was probably able to inhibit the gliadin-induced
damage to Caco-2 cells breaking up wheat gliadin into
small harmless peptide products [43]. Thirdly, L.GG might
modulate directly the function of epithelial cells. It has
already been reported that different probiotic strains, pro-
biotic bacterial lysates or conditioned medium increase
epithelial barrier function as measured by TER [44]. In
addition, L.GG might protect the epithelium from the gli-
adin insult by direct action on the cells.
One interesting finding of the present study is that vi-
able L.GG per se was able to significantly increase ZO-1,
Claudin-1 and Occludin expression after 6 h of expos-
ure. Even if the gliadin effects on TJ expression were sig-
nificant only after 24 h, the co-administration of viable
L.GG with gliadin caused an early and significant in-
crease in the expression of the tested proteins compared
to gliadin treated cells. Besides, after 24 h, viable L.GG
with gliadin continued to significantly increase the ex-
pression of Claudin-1 and Occludin, but exerted only a
slight and not significant decrease on ZO-1 levels. Avail-
able data support the capability of peculiar probiotic
strains in modulating TJ protein expression. Pretreat-
ment of Caco-2 monolayers with L. plantarum signifi-
cantly attenuated the effects of phorbol ester-induced
dislocation of ZO-1 and Occludin and the associated in-
crease in epithelial permeability [45]. Additionally, treat-
ment of Caco-2 cells with the probiotic L. plantarum
MB452 resulted in augmented transcription of Occludin
and Cingulin genes, suggesting that bacteria-induced im-
provements to intestinal barrier integrity may also be
regulated at the gene expression level [46].
Of note, the presence of polyamines was required for vi-
able L.GG to exert its effects on TJ expression. As a mat-
ter of fact, when Caco-2 monolayers were deprived in the
polyamine content by DFMO, the expression of TJ pro-
teins was not significantly different from that in controls
or cells treated with gliadin alone. Cellular polyamines
spermidine, spermine and their precursor putrescine, have
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intestinal epithelial integrity by their ability to modulate
expression and functions of various genes, such as inter-
cellular junction proteins [12]. Present findings let us
hypothesize that the action of viable L.GG in modulat-
ing the expression of TJ proteins could be mediated also
by the presence of cellular polyamines, although the exact
mechanisms are still not completely elucidated. Possibly,
they may be related to the specific molecular structure of
these compounds. At physiological pH, putrescine, spermi-
dine, and spermine possess two, three, and four positive
charges, respectively [47]. These compounds can bind to
negatively charged macromolecules such as DNA, RNA,
and proteins to influence the sequence-specific DNA-,
RNA- or protein-protein interactions, which alter gene
transcription and translation and the stability of mRNAs
and proteins.Conclusions
The present study demonstrates that gliadin is able to
alter the intestinal paracellular permeability and to signifi-
cantly increase the polyamine content in Caco-2 cells.
Concomitant administration of L.GG counteracts these ef-
fects. Interestingly, the presence of cellular polyamines is a
pre-requisite for this probiotic to exert its capability in re-
storing paracellular permeability by affecting the expres-
sion of different TJ proteins.
For CD patients, a lifetime adherence to a strict GFD
treatment is difficult to follow. Thus, alternative therap-
ies for CD are being hypothesized, including agents that
reduce gluten exposure by either binding or degrading
gluten in the intestinal lumen or prevent gluten uptake
into the mucosa. In this perspective, probiotic strains
such as L.GG, not only as viable bacteria, but also in its
heat inactivated form or conditioned medium may play
a role in protecting intestinal mucosa from gliadin in-
duced damage.
The complex relationship between probiotics and
polyamines as well as the role played by these amines in
maintenance of intestinal epithelial integrity justify fur-
ther studies. Research will be addressed to investigate
the role of polyamines by evaluating not only the en-
zymes involved in the regulation of their production and
degradation, but also considering in vivo study design on
animal model of gluten-sensitive enteropathy [48].Abbreviations
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